Clinical Trial Update: Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

View source ↗

Summary

The expanded access program for tazemetostat in adults with epithelioid sarcoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelioid Sarcoma

Drugs mentioned

• Tazemetostat (tazemetostat)

Snippet

Sponsor: Epizyme, Inc. | Conditions: Epithelioid Sarcoma | Status: NO_LONGER_AVAILABLE